Tagged: Research

Update from the Dean - September 2017

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership; Tobacco burden in vulnerable populations; Economics of disease; Precision medicine.

Craik elected member of American Academy of Arts and Sciences

Charles S. Craik, PhD, joins the 237th class of newly elected members of the prestigious American Academy of Arts and Sciences who will be inducted on October 7, 2017 at a ceremony in Cambridge, Massachusetts. Craik is a faculty member in the School’s Department of Pharmaceutical Chemistry and director of the Quantitative Biosciences Consortium (a consortium of five UCSF PhD degree programs).

UCSF School of Pharmacy leads in NIH funding for 37th year in a row

For the 37th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States. School researchers were awarded $28.2 million in grants during NIH’s 2016 fiscal year, from October 1, 2015 to September 30, 2016.

Among the top-funded researchers was Kathy Giacomini, PhD, a faculty member in the School’s department of Bioengineering and Therapeutic Sciences.

Prien and MacWilliam bequests establish new endowed professorships

The UCSF School of Pharmacy has established new endowed faculty positions to be held by the chairs of two School departments.

Giacomini honored with ASCPT distinguished service award

Kathy Giacomini, PhD, has been named the 2017 recipient of the Henry W. Elliott Distinguished Service Award from the American Society for Clinical Pharmacology and Therapeutics (ASCPT).

Founded in 1900, ASCPT comprises more than 2,200 members whose primary interest is to advance the science and practice of clinical pharmacology and translational medicine.

Gartner to co-direct new UCSF-based Center for Cellular Construction

UCSF School of Pharmacy faculty member Zev Gartner, PhD, will be co-director of a new multi-institution UCSF-administered Center for Cellular Construction, which has been awarded a five-year $24 million grant by the National Science Foundation (NSF).

Aweeka study details impact of HIV drugs on malaria treatment in children

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

Pages